Histone Methyltransferase
Histone Methyltransferase(组蛋白甲基转移酶)
Histone methyltransferases are a group of enzymes that catalyze the methylation of histone lysine and arginine by adding methyl groups to specific histone arginine or lysine residues. Histone methyltransferaes can be classified into 3 classes, including SET domain lysine methyltransferases, non-SET domain lysine methyltransferases and arginine methyltransferases (PRMTs), all of which use S-adenosylmethionine as a cosubstrate for the transfer of the methyl group. Aberrant histone methylation has been associated with a wide range of human cancers (such as hematological malignancies), which leads to the development of novel cancer chemotherapies targeting cancer-associated histone methyltransferases (more than 20 lysine methyltransferases and 9 arginine methyltransferases in humans).
Histone Methyltransferase 相关产品(238)
- GC36969PRMT5-IN-1CAS: 2366149-83-7
PRMT5 IN-1 是一种半缩醛胺,共价的蛋白质精氨酸甲基转移酶5 (PRMT5) 抑制剂,对 PRMT5/MEP50 的 IC50 为 11 nM。PRMT5 IN-1在生理条件下可以转化为醛并与 C449 反应形成共价加合物。
- GC37881Valemetostat tosylateCAS: 1809336-93-3纯度: >99.50%
Valemetostat tosylate (DS-3201 tosylate) 是一种首创的 EZH1/2 抑制剂,用于复发/难治性周围 T 细胞淋巴瘤的研究。
- GC38062Gambogenic acidCAS: 173932-75-7纯度: >99.50% / >98.00%
Gambogenic acid是藤黄的主要活性成分,能抑制Aurora A激酶,IC 50 值为1.425μM。
- GC38163Tazemetostat hydrobromideCAS: 1467052-75-0纯度: >99.00%
Tazemetostat hydrobromide (EPZ-6438 hydrobromide) 是一种有效,选择性,口服的 EZH2 抑制剂。Tazemetostat hydrobromide 抑制含有 PRC2 复合体的野生型 EZH2 的活性, Ki 值为 2.5±0.5 nM。Tazemetostat hydrobromide 抑制 EZH2,在肽测定和核小体测定中 IC50 分别为 11 和 16 nM。Tazemetostat hydrobromide 抑制大鼠 EZH2,IC50 为 4 nM。Tazemetostat hydrobromide 还抑制 EZH1,IC50 为 392 nM。
- GC39663BI-9321 trihydrochlorideCAS: 2387510-87-2纯度: >98.50%
BI-9321 trihydrochloride 是一种有效的,选择性的,具有细胞活性的 NSD3-PWWP1 拮抗剂,Kd 值为 166 nM。BI-9321 对 NSD2-PWWP1 和 NSD3-PWWP2 无效。BI-9321 trihydrochloride 在 U2OS 细胞中特异性破坏 NSD3-PWWP1 与组蛋白相互作用,IC50 为 1.2 μM。
- GC39840AMI-1 free acidCAS: 134-47-4纯度: >97.00%
AMI-1 is a potent and specific Histone Methyltransferase (HMT) inhibitor with IC50 of 3.0 μM and 8.8 μM for yeast Hmt1p and human PRMT1, respectively.
- GC42790AmodiaquineCAS: 86-42-0纯度: >98.00%
Amodiaquine是一种4-氨基喹啉类化合物,主要用于疟疾的治疗,还具有抗炎、抗病毒作用。Amodiaquine是一种核受体Nurr1激动剂,EC 50 值约为20μM。
- GC42944BIX01294 (hydrochloride hydrate)CAS: 1808255-64-2纯度: >98.00%
An inhibitor of G9a histone methyltransferase
- GC43715Furamidine (hydrochloride)CAS: 55368-40-6纯度: >98.00%
A selective PRMT1 inhibitor and antiprotozoal agent
- GC43837Histone H3 Peptide Substrate (1-21)纯度: >95.00%
Target substrate for several histone modifying enzymes
- GC44859S-(5'-Adenosyl)-L-methionine chloride (hydrochloride)CAS: 86867-01-8纯度: >95.00%
Ubiquitous methyl donor
- GC44886S-Farnesyl Thioacetic AcidCAS: 135784-48-4纯度: >97.00%
A competitive inhibitor of SAM-dependent methyltransferase
- GC45763Tolcapone-d4CAS: 1246816-93-2纯度: >99.00%
An internal standard for the quantification of tolcapone
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC36656 | MS049 | 1502816-23-0 | >98.00% | |
A selective, dual PRMT4/PRMT6 inhibitor | ||||
| GC36969 | PRMT5-IN-1 | 2366149-83-7 | - | |
PRMT5 IN-1 是一种半缩醛胺,共价的蛋白质精氨酸甲基转移酶5 (PRMT5) 抑制剂,对 PRMT5/MEP50 的 IC50 为 11 nM。PRMT5 IN-1在生理条件下可以转化为醛并与 C449 反应形成共价加合物。 | ||||
| GC37654 | SMYD3-IN-1 | 2095160-79-3 | - | |
SMYD3-IN-1 (compound 29) 是一种不可逆的、选择性的SMYD3 的抑制剂,其IC50 值为 11.7 nM。 | ||||
| GC37856 | UNC0321 | 1238673-32-9 | >98.00% | |
A highly potent inhibitor of G9a histone methyltransferase | ||||
| GC37881 | Valemetostat tosylate | 1809336-93-3 | >99.50% | |
Valemetostat tosylate (DS-3201 tosylate) 是一种首创的 EZH1/2 抑制剂,用于复发/难治性周围 T 细胞淋巴瘤的研究。 | ||||
| GC38062 | Gambogenic acid | 173932-75-7 | >99.50% / >98.00% | |
Gambogenic acid是藤黄的主要活性成分,能抑制Aurora A激酶,IC 50 值为1.425μM。 | ||||
| GC38163 | Tazemetostat hydrobromide | 1467052-75-0 | >99.00% | |
Tazemetostat hydrobromide (EPZ-6438 hydrobromide) 是一种有效,选择性,口服的 EZH2 抑制剂。Tazemetostat hydrobromide 抑制含有 PRC2 复合体的野生型 EZH2 的活性, Ki 值为 2.5±0.5 nM。Tazemetostat hydrobromide 抑制 EZH2,在肽测定和核小体测定中 IC50 分别为 11 和 16 nM。Tazemetostat hydrobromide 抑制大鼠 EZH2,IC50 为 4 nM。Tazemetostat hydrobromide 还抑制 EZH1,IC50 为 392 nM。 | ||||
| GC39407 | MS1943 | 2225938-17-8 | >98.00% | |
A PROTAC that drives EZH2 degradation | ||||
| GC39663 | BI-9321 trihydrochloride | 2387510-87-2 | >98.50% | |
BI-9321 trihydrochloride 是一种有效的,选择性的,具有细胞活性的 NSD3-PWWP1 拮抗剂,Kd 值为 166 nM。BI-9321 对 NSD2-PWWP1 和 NSD3-PWWP2 无效。BI-9321 trihydrochloride 在 U2OS 细胞中特异性破坏 NSD3-PWWP1 与组蛋白相互作用,IC50 为 1.2 μM。 | ||||
| GC39665 | CMP-5 | 880813-42-3 | >98.50% | |
CMP-5 是一种有效的选择性 PRMT5 抑制剂,对 PRMT1,PRMT4 和 PRMT7 酶无活性。CMP-5 在组蛋白的准备过程中,通过抑制 PRMT5 甲基转移酶活性选择性地阻断 S2Me-H4R3。CMP-5 阻断 EBV 驱动的 B 淋巴细胞转化,但对正常 B 细胞没有影响。 | ||||
| GC39840 | AMI-1 free acid | 134-47-4 | >97.00% | |
AMI-1 is a potent and specific Histone Methyltransferase (HMT) inhibitor with IC50 of 3.0 μM and 8.8 μM for yeast Hmt1p and human PRMT1, respectively. | ||||
| GC41263 | TP-064 | 2080306-20-1 | >98.00% | |
A potent inhibitor of PRMT4 | ||||
| GC42784 | AMI-1 (sodium salt) | - | >99.00% | |
A cell permeable inhibitor of PRMTs | ||||
| GC42790 | Amodiaquine | 86-42-0 | >98.00% | |
Amodiaquine是一种4-氨基喹啉类化合物,主要用于疟疾的治疗,还具有抗炎、抗病毒作用。Amodiaquine是一种核受体Nurr1激动剂,EC 50 值约为20μM。 | ||||
| GC42944 | BIX01294 (hydrochloride hydrate) | 1808255-64-2 | >98.00% | |
An inhibitor of G9a histone methyltransferase | ||||
| GC43354 | Cysmethynil | 851636-83-4 | >98.00% | |
An inhibitor of protein prenylation | ||||
| GC43715 | Furamidine (hydrochloride) | 55368-40-6 | >98.00% | |
A selective PRMT1 inhibitor and antiprotozoal agent | ||||
| GC43837 | Histone H3 Peptide Substrate (1-21) | - | >95.00% | |
Target substrate for several histone modifying enzymes | ||||
| GC44859 | S-(5'-Adenosyl)-L-methionine chloride (hydrochloride) | 86867-01-8 | >95.00% | |
Ubiquitous methyl donor | ||||
| GC44886 | S-Farnesyl Thioacetic Acid | 135784-48-4 | >97.00% | |
A competitive inhibitor of SAM-dependent methyltransferase | ||||
| GC45117 | UNC2327 | 1426152-53-5 | >98.00% | |
An allosteric inhibitor of PRMT3 | ||||
| GC45389 | BAY-6035 | 2247890-13-5 | >95.00% | |
An inhibitor of SMYD3 | ||||
| GC45609 | ZLD1039 | 1826865-46-6 | >98.00% | |
An inhibitor of EZH2 | ||||
| GC45763 | Tolcapone-d4 | 1246816-93-2 | >99.00% | |
An internal standard for the quantification of tolcapone | ||||
